Prolonged Support Using a Percutaneous OxyRVAD in a Patient with End-Stage Lung Disease, Pulmonary Hypertension, and Right Cardiac Failure

ASAIO J. 2016 Jul-Aug;62(4):e37-40. doi: 10.1097/MAT.0000000000000343.

Abstract

Options for cardiopulmonary support in patients with severe pulmonary hypertension (PH) that is not associated with left-sided heart failure are limited. We describe the novel use of prolonged percutaneous venovenous extracorporeal membrane oxygenation as a right ventricular assist device in a patient presenting with cardiogenic shock because of severe PH decompensation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Heart Failure / therapy*
  • Heart-Assist Devices*
  • Humans
  • Hypertension, Pulmonary / therapy*
  • Shock, Cardiogenic / etiology
  • Ventricular Dysfunction, Right / therapy*